Xuxia Wang

Mrs. Xuxia Wang


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Theranostics
Verified
Journal Article
Open access
PDF file
MWMinghuan Wang
Minghuan Wang
CQChuan Qin
Chuan Qin
XLXiang Luo
Xiang Luo
JWJie Wang
Jie Wang
XWXuxia Wang
Xuxia Wang
WWWei Wang
Wei Wang
Rational: Myelin loss is a characteristic feature of both ischemic white matter disease and its associated vascular dementia, and is a hallmark of chronic cerebral hypoperfusion due to carotid artery stenosis. Yet the cellular mechanisms involved in ischemic dysmyelination are not well-understood, and no effective treatment has emerged to prevent or slow hypoperfusion-related demyelination. In a study employing the bilateral common carotid artery stenosis (BCAS) mouse model, we found reduced cerebral blood flow velocity and arteriolar pulsatility, and confirmed that prolonged BCAS provoked myelin disruption. These pathological features were associated with marked cognitive decline, in the absence of evident damage to axons.

12 February 2021 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Closed access
CWCaixia Wang
Caixia Wang
LSLi Su
Li Su
QMQiuling Mu
Qiuling Mu
XGXueyan Gu
Xueyan Gu
XGXuejun Guo
Xuejun Guo
XWXuxia Wang
Xuxia Wang
Background: The first Chinese domestic 13-valent pneumococcal conjugate vaccine (WoAnxin®, PCV-13) is available for children aged 2 months to 5 years and is more economical than import vaccine with equal safety and immunogenicity. However, the cost-effectiveness of this new PCV-13 for children <5 years in mainland China is not clear. Methods: In the present study, we developed a Markov model under societal perspective to evaluate the incremental cost-effectiveness ratios (ICERs) of five birth cohorts of 100,000 Chinese infants across four alternative vaccination programs:1) no vaccination; 2) vaccinate 4 doses of new PCV-13 for children aged 2 to 6 months; 3) vaccinate 3 doses of new PCV-13 for children aged 7 to 11 months; 4) vaccinate 2 doses of new PCV-13 for children aged 12 to 23 months; 5) vaccinate 1 dose of new PCV-13 for children aged 2 to 5 years. We conducted one-way and probability sensitivity analysis to determine the uncertainty of the model findings. Results: We found that with awillingness-to-pay (WTP) threshold of three-times Chinese per-capita gross domestic product (GDP) all vaccination programs were cost-effective compared to no vaccination and children aged 2 to 5 years received 1 dose of new PCV-13 would incur the lowest additional cost of US$2417 per quality-adjusted-life-years (QALYs) compare with other vaccination programs ($15394/QALYs for 4 doses program, $9292/QALYs for 3 doses program, $4445/QALYs for 2 doses program). Conclusions: According to our results, China should give priority to incorporating new PCV-13 into its national immunization program.

21 October 2021 in Annals of Global Health
Verified
Journal Article
Open access
PDF file
XWXuxia Wang
Xuxia Wang
LSLi Su
Li Su
SSShougang Sun
Shougang Sun
WHWenbiao Hu
Wenbiao Hu
QMQiuling Mu
Qiuling Mu
GZGuihua Zhuang
Guihua Zhuang
The study aimed to evaluate the long-term neurological sequelae and the disease burden of JE in Gansu, China. JE patients were included as study population from 2005–2011 in Gansu, and a follow-up survey was conducted in 2007–2014. Pair-matched healthy individuals were selected as controls. All subjects underwent a neurological examination and intelligence quotient (IQ) and memory quotient (MQ) assessments. Then, the disability-adjusted life years (DALYs), and direct and indirect medical expenses were systematic assessed. Forty-four point seven percent of the JE patients had objective neurological deficits, compared with 2.4% of controls. Subnormal intelligence was found in 21.2% of JE subjects, compared with 1.2% control who exhibited a mildly reduced IQ. Abnormal MQ scores were noted in 56.3% JE subjects, compared with only 12.7% controls. Prevalence of each sequelae caused by JE were significantly higher in adults than in younger subjects. Furthermore, median DALY lost due to JE was 9.2 per subject. Median economic cost of JE was approximately $2776.6 per subject and significantly higher in adults than in younger subjects. JE patients suffered from severe neurological sequelae and high disease burden, resulting in a significant downstream burden for both the patients (especially adults) and the healthcare system.

23 February 2023 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
RLRuifen Li
Ruifen Li
XZXiaohong Zhao
Xiaohong Zhao
YTYu Tian
Yu Tian
YSYanjun Shi
Yanjun Shi
XGXueyan Gu
Xueyan Gu
XWXuxia Wang
Xuxia Wang
This study evaluated epidemic temporal aspects of Japanese encephalitis (JE) and investigated the weather threshold of JE response across eight climate subtypes between 2005 and 2019 in Gansu Province, China. Epidemiological data were collected from the China Information System for Disease Control and Prevention (CISDCP). Three epidemic temporal indices [frequency index (α), duration index (β), and intensity index (γ)] were adopted for the comparison of epidemic features among different climate subtypes. In addition, the local indicators of spatial association (LISA) technique was used to detect the hot-spot areas. The category and regression tree (CART) model was used to detect the response threshold of weather variables in hot-spot areas across climate subtypes. Among eight climate subtypes in Gansu, in most hot-spot areas (i.e., high–high clusters), α, β, and γ were detected in the climate subtypes of subtropical winter dry (Cwa), temperate oceanic continental (Cwb), and continental winter dry (Dwa and Dwb). According to the CART analysis, a minimum monthly temperature is required for Japanese encephalitis virus (JEV) transmission, with different threshold values among the climatic subtypes. In temperate climate zones (Cwa and Cwb), this threshold is 19 °C at a 1-month lag. It is lower in continental winter dry climate zones: 18 °C in Dwa (snow climate, dry winter, and hot summer) and 16 °C in Dwb (snow climate, dry winter, and warm summer). Additionally, some areas of the areas with temperate arid (BWk and BSk) had the first JE cases. Further studies to detect whether the climate change influence the JEV’s distribution in Gansu Province are needed.

5 August 2022 in Research Square
Verified
Preprint
Open access
PDF file
RLRuifen Li
Ruifen Li
XZXiaohong Zhao
Xiaohong Zhao
YTYu Tian
Yu Tian
YSYanjun Shi
Yanjun Shi
XGXueyan Gu
Xueyan Gu
XWXuxia Wang
Xuxia Wang
This study evaluated epidemic temporal aspects of Japanese Encephalitis (JE) and investigated the weather threshold of JE response across eight climate subtypes between 2005 and 2019 in Gansu. Data were from the Centers for Disease Control (CDC) of Gansu. Three epidemic temporal indices (frequency index (α), duration index (β), and intensity index (γ)) were adopted for the comparison of epidemic features among different climate subtypes. In addition, the local indicators of spatial association technique (LISA) and category and regression tree model (CART) were used to detect the response threshold of weather variables in hot-spot areas across climate subtypes. Among eight climate subtypes in Gansu, a hot-spot(high-high cluster) of α, β, and γ were detected in the climate subtype of subtropical winter dry (Cwa), temperate oceanic continental (Cwb), and continental winter dry (Dwa, and the Dwb). CART analysis showed that the average temperature at a 1-month lag for JE may be the strongest predictor of JE response in Cwa. However, the maximum temperature at a 1-month lag for JE may be the strongest predictor of JE response in Cwb, Dwa, and Dwb.The climate subtypes of temperate arid (BWk) and subpolar winter dry (Dwc) in Gansu may be at the epicenter of an emerging pandemic. It is critical to increase preventive and control efforts in these areas. Cwa, Cwb, Dwa, and Dwb are the high-risk JE epidemic areas, where JE temperature at the lag of 1 month is the predominant variable of JE response.